Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Allurion Technologies, Inc.

< Previous 1 2 Next >
Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Launch of Offering of Common Stock and Warrants
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Preliminary First Quarter 2024 Results
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Expands Virtual Care Suite to the United States
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in the Jefferies London Healthcare Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.